• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Scar Tissue (2060); Visual Impairment (2138); Burning Sensation (2146); Arthralgia (2355); Malaise (2359); Palpitations (2467)
Event Date 08/27/2007
Event Type  Injury  
Manufacturer Narrative
Unknown taper.This event was reported by the patient.To date, apollo has been unable to confirm the reported events with the patient's physician.Device labeling addresses the reported event as follows: precautions: over-dissection of the stomach during placement may result in slippage or erosion of the band and require reoperation.Adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures there is a risk of band erosion into the stomach tissue.Erosion of the band into the stomach tissue has been associated with revision surgery after the use of gastric-irritating medications, after stomach damage and after extensive dissection or use of electrocautery, and during early experience.Symptoms of band erosion may include reduced weight loss, weight gain, access port infection or abdominal pain.Reoperation to remove the device is required.Nausea and vomiting may occur, particularly in the first few days after surgery and when the patient eats more than recommended.Nausea and vomiting may also be symptoms of stoma obstruction or a band/ stomach slippage.Frequent, severe vomiting can result in pouch dilatation, stomach slippage or esophageal dilatation.Deflation of the band is immediately indicated in all of these situations.Deflation of the band may alleviate excessively rapid weight loss and nausea and vomiting.Reoperation to reposition or remove the device may be required.Infection can occur in the immediate post-operative period or years after insertion of the device.In the presence of infection or contamination, removal of the device is indicated.Other adverse events considered related to the lap-band® system that occurred in fewer than 1% of subjects included: esophagitis, gastritis, hiatal hernia, pancreatitis, abdominal pain, hernia, incisional infection, infection, redundant skin, dehydration, gi perforation, diarrhea, abnormal stools, constipation, flatulence, dyspepsia, eructation, cardiospasm, hematemesis, asthenia, fever, chest pain, incision pain, contact dermatitis, abnormal healing, edema, paresthesia, dysmenorrhea, hypochromic anemia, band leak, cholecystitis, esophageal dysmotility, esophageal ulcer, esophagitis, port displacement, port site pain, spleen injury and wound infection.
 
Event Description
Reported as: a patient with the lap-band system was reported to have received one fill the entire life of the band.Patient started having severe gastric issues-bloat, indigestion, severe pain, bowel inflammation and associated aliments."pain worsened through the years and extended to my joints.Referred to several different doctors to determine pain.I received several "test", treatments, medicines and procedures to discover the problem." patient went to the "emergency room after realizing the pain was so bad." the er physician "had discovered my lap-band had eroded completely through my stomach and severe infection had set in.I had emergency surgery to remove it.Post-surgery, i have had numerous issues, including re-hospitalization, infections, the inability to digest food without severe pain, the inability to pass through my intestines without severe pain and abdominal bowel movement, the inability to drink fluids without burning sensations through my esophagus, and severe weakness due to malnutrition.My diabetes has become difficult to control and i'm having associated nephropathy, situational blindness/vision impairments, and cardiac palpitations.The scar tissue and damage from the lap-band has permanently scarred my life - physically and emotionally.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND SYSTEM
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia,
CS  
Manufacturer Contact
laura leboeuf
1120 s. capital of texas hwy
bldg 1, ste. 300
austin, TX 78746
MDR Report Key8110393
MDR Text Key128586417
Report Number3006722112-2018-00307
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial
Report Date 10/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/30/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GLIPIZIDE; METFORMIN
Patient Outcome(s) Hospitalization; Required Intervention;
-
-